The BDNF/TrkB signaling pathway seems to have functions with tumor progression, such as peritoneal carcinomatosis [26], bladder cancer [27], and non-small cell lung cancer [28]. This evidence concerns the gene NTRK2 and urinary bladder carcinoma.